Biden signs law capping commercial insulin copays at $35 for thirty-day supply
President Biden signed a bipartisan bill in Washington to cap commercial insulin prices at $35 for a thirty-day supply. The law limits out-of-pocket costs for millions of privately insured Americans and requires drugmakers to pay rebates if prices rise above inflation. Insulin manufacturers must begin reporting prices and rebates to federal regulators within six months.
Where this came from. One outlet reported this. We read it, then wrote the sixty words above.